UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Massive ex vivo expansion of human natural regulatory T cells (T(regs)) with minimal loss of in vivo functional activity

Science translational medicine, 2011-05, Vol.3 (83), p.83ra41

2011

Volltextzugriff (PDF)

Optimization of cGMP purification and expansion of umbilical cord blood–derived T-regulatory cells in support of first-in-human clinical trials

Cytotherapy (Oxford, England), 2017-02, Vol.19 (2), p.250-262

2017

Volltextzugriff (PDF)

Good manufacturing practices production of natural killer cells for immunotherapy: a six-year single-institution experience

Transfusion (Philadelphia, Pa.), 2007-03, Vol.47 (3), p.520-528

2007

Volltextzugriff (PDF)

Successful "in-flight" activation of natural killer cells during long-distance shipping

Transfusion (Philadelphia, Pa.), 2013-02, Vol.53 (2), p.398-403

2013

Volltextzugriff (PDF)

Clinical production and therapeutic applications of alloreactive natural killer cells

Methods in molecular biology (Clifton, N.J.), 2012, Vol.882, p.491

2012

Volltextzugriff (PDF)

The Minnesota Molecular and Cellular Therapeutics Facility: A State-of-the-Art Biotherapeutics Engineering Laboratory

Transfusion medicine reviews, 2005-07, Vol.19 (3), p.217-228

2005

Volltextzugriff (PDF)

Cellular Engineering of HSV-tk Transduced, Expanded T Lymphocytes for Graft-versus-Host Disease Management

Acta Haematologica, 2003, Vol.110 (2-3), p.121-131

2003

Volltextzugriff (PDF)

Staffing, Training, and Competency

Cell Therapy, 2022, p.443-458

2022

Volltextzugriff (PDF)

Cellular engineering of HSV-tk transduced, expanded T lymphocytes for graft-versus-host disease management: Gene- and immunotherapy for hematological diseases

Acta haematologica, 2003, Vol.110 (2-3), p.121-131

2003

Volltextzugriff (PDF)

Results of a phase 1, randomized, double-blind, placebo-controlled trial of bone marrow mononuclear stem cell administration in patients following ST-elevation myocardial infarction

The American heart journal, 2010-09, Vol.160 (3), p.428-434

2010

Volltextzugriff (PDF)

Clinical‐scale production of cGMP compliant CD3/CD19 cell‐depleted NK cells in the evolution of NK cell immunotherapy at a single institution

Transfusion (Philadelphia, Pa.), 2018-06, Vol.58 (6), p.1458-1467

2018

Volltextzugriff (PDF)

Patient care during infusion of hematopoietic progenitor cells

Transfusion (Philadelphia, Pa.), 2004-06, Vol.44 (6), p.907-916

2004

Volltextzugriff (PDF)

BMT Product Infusion Flowsheet and Product Infusion Note

Biology of blood and marrow transplantation, 2016-03, Vol.22 (3), p.S432-S433

2016

Volltextzugriff (PDF)

1 – 13 von 13

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(10)
Mit Volltextzugriff
(11)

Publikationsform

Artikel
(12)
Buchkapitel
(1)

Sprache

Englisch
(13)

Erscheinungsjahr

n.n

Menü

Weitere Dienste

Einstellungen

Massive ex vivo expansion of human natural regulatory T cells (T(regs)) with minimal loss of in vivo functional activity

Optimization of cGMP purification and expansion of umbilical cord blood–derived T-regulatory cells in support of first-in-human clinical trials

Good manufacturing practices production of natural killer cells for immunotherapy: a six-year single-institution experience

Successful "in-flight" activation of natural killer cells during long-distance shipping

Clinical production and therapeutic applications of alloreactive natural killer cells

The Minnesota Molecular and Cellular Therapeutics Facility: A State-of-the-Art Biotherapeutics Engineering Laboratory

Cellular Engineering of HSV-tk Transduced, Expanded T Lymphocytes for Graft-versus-Host Disease Management

Staffing, Training, and Competency

Cellular engineering of HSV-tk transduced, expanded T lymphocytes for graft-versus-host disease management: Gene- and immunotherapy for hematological diseases

Results of a phase 1, randomized, double-blind, placebo-controlled trial of bone marrow mononuclear stem cell administration in patients following ST-elevation myocardial infarction

Clinical‐scale production of cGMP compliant CD3/CD19 cell‐depleted NK cells in the evolution of NK cell immunotherapy at a single institution

Patient care during infusion of hematopoietic progenitor cells

BMT Product Infusion Flowsheet and Product Infusion Note

Suchergebnisse filtern